Title : Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients.

Pub. Date : 2012 Mar 14

PMID : 22419339






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Currently, more than 90% of all liver transplant recipients are treated with the calcineurin inhibitor cyclosporine or tacrolimus. Cyclosporine calcineurin binding protein 1 Homo sapiens
2 This ongoing trial studies total withdrawal of immunosuppression in patients who receive a calcineurin inhibitor (cyclosporine or tacrolimus) or mycophenolate mofetil as the only immunosuppressive agent. Cyclosporine calcineurin binding protein 1 Homo sapiens